Diaziquone (Diaziquone) is a water-soluble, synthetic aziridinylbenzoquinone with potential antineoplastic activity.
Diaziquone (6.75mg /sq m daily for 5 consecutive days or single-dose 26 mg/sq m) has a broad range of activity of diaziquone against primary nervous system tumors and has enhancement effect combined with either 1,3-bis(2-chloroetl)-1-nitrosourea or procarbazine in atmic mice[1].
References:
[1]. S C Schold Jr, et al. Treatment of human glioma and medulloblastoma tumor lines in atmic mice with diaziquone and diaziquone-based drug combinations. Cancer Res. 1984 Jun;44(6):2352-7.